NEW YORK ( TheStreet) -- Enzon Pharmaceuticals (Nasdaq: ENZN) hit a new 52-week low Thursday as it is currently trading at $8.86, below its previous 52-week low of $9.09 with 130,992 shares traded as of 11 a.m. ET. Average volume has been 392,200 shares over the past 30 days. Enzon has a market cap of $499.8 million and is part of the health care sector and drugs industry. Shares are down 23% year to date as of the close of trading on Wednesday. Enzon Pharmaceuticals, Inc., a biotechnology company, engages in the research and development of therapeutics for cancer patients with unmet medical needs.
- Practice your ENZN trading strategies and win cash in our stock game.